Free provider profile
SRISAI GOWDA, M.D.
NPI 1801995352
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2019-12-13.
#2106, NEW ROAD D-8, LINWOOD, NJ, 08221
609-927-1030
Single practice location
Enumerated 2006-09-21
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 1 payer identifiers on file — enrolled with payers.
- — Record last updated 6 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,273
Medicare patients
184
Part D drug cost
$161,969
Brand-name share
5.5%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Invega Sustenna (Paliperidone Palmitate) | 13 | $41,424 |
| Vivitrol (Naltrexone Microspheres) | 12 | $18,512 |
| Lybalvi (Olanzapine/Samidorphan Malate) | 12 | $17,719 |
| Aripiprazole (Aripiprazole) | 85 | $4,687 |
| Olanzapine (Olanzapine) | 122 | $3,063 |
| Quetiapine Fumarate (Quetiapine Fumarate) | 94 | $1,765 |
| Desvenlafaxine Succinate Er (Desvenlafaxine Succinate) | 15 | $1,721 |
| Venlafaxine Hcl Er (Venlafaxine Hcl) | 75 | $1,271 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024124 sessions · 16 patients · $124,239
202395 sessions · 12 patients · $93,977
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.